India's Eris Lifesciences to buy some dermatology brands from Glenmark Pharma
BENGALURU, Jan 17 (Reuters) - Indian drugmaker Eris Lifesciences Ltd ERIS said on Tuesday it would acquire a portfolio of dermatology brands from Glenmark Pharmaceuticals Ltd GLEN.NS for 3.4 billion rupees ($41.63 million) ($1 = 81.6740 Indian rupees) (Reporting by Yagnoseni Das in Bengaluru; Editing by Shailesh Kuber) ((Yagnoseni.Das@thomsonreuters.com; +91 6001289066))
Recent news on Eris Lifesciences
See all newsIndia's Eris Lifesciences gains on strong quarterly results
Brief: Eris Lifesciences Sept-Quarter Consol Net Profit 1.84 Billion Rupees
Brief: Eris Lifesciences Says Krishnakumar Vaidyanathan Resigns As Executive Director & COO
Brief: Eris Lifesciences Ltd Says June-Quarter Consol Net Profit 1.42 Billion Rupees
Brief: Eris Lifesciences March-Quarter Consol Net Profit 2.82 Billion Rupees